Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-10-25 Purchase | 2023-10-27 4:15 pm | Aligos Therapeutics Inc. | ALGS | Nuechterlein Carole Director 10% Owner | 7,933,601 | $0.7568 | $6,004,149 | 14,992,741 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-10-08 Option Award | 2024-10-10 4:16 pm | N/A 2034-10-08 | Aligos Therapeutics Inc. | ALGS | Achneck Hardean Chief Medical Officer | 75,000 | $0 | 75,000 (Direct) | View |
| 2024-09-04 Option Award | 2024-09-06 4:23 pm | N/A 2034-09-04 | Aligos Therapeutics Inc. | ALGS | Calhoun Lesley Ann See Remarks | 10,880 | $0 | 10,880 (Direct) | View |
| 2024-09-04 Option Award | 2024-09-06 4:23 pm | N/A 2034-09-04 | Aligos Therapeutics Inc. | ALGS | BLATT LAWRENCE Chief Executive Officer | 33,920 | $0 | 33,920 (Direct) | View |
| 2024-09-04 Option Award | 2024-09-06 4:22 pm | N/A 2034-09-04 | Aligos Therapeutics Inc. | ALGS | Symons Julian A. See Remarks | 10,880 | $0 | 10,880 (Direct) | View |
| 2024-08-07 Option Award | 2024-08-09 4:09 pm | N/A 2034-08-07 | Aligos Therapeutics Inc. | ALGS | Chavez Margarita Director | 120,000 | $0 | 120,000 (Direct) | View |
| 2024-08-07 Option Award | 2024-08-09 4:08 pm | N/A 2034-08-07 | Aligos Therapeutics Inc. | ALGS | Preston Heather Director | 120,000 | $0 | 120,000 (Direct) | View |
| 2024-06-27 Option Award | 2024-06-28 4:08 pm | N/A 2034-06-27 | Aligos Therapeutics Inc. | ALGS | Hirth Peter Director | 60,000 | $0 | 60,000 (Direct) | View |
| 2024-06-27 Option Award | 2024-06-28 4:08 pm | N/A 2034-06-27 | Aligos Therapeutics Inc. | ALGS | Nuechterlein Carole Director | 60,000 | $0 | 60,000 (Direct) | View |
| 2024-06-27 Option Award | 2024-06-28 4:07 pm | N/A 2034-06-27 | Aligos Therapeutics Inc. | ALGS | Scopa James Paul Director | 60,000 | $0 | 60,000 (Direct) | View |
| 2024-06-27 Option Award | 2024-06-28 4:07 pm | N/A 2034-06-27 | Aligos Therapeutics Inc. | ALGS | Martell Bridget A Director | 60,000 | $0 | 60,000 (Direct) | View |
| 2024-03-01 Option Award | 2024-03-04 5:44 pm | N/A 2034-03-01 | Aligos Therapeutics Inc. | ALGS | McClure Matthew W. Chief Medical Officer | 72,000 | $0 | 72,000 (Direct) | View |
| 2024-03-01 Option Award | 2024-03-04 5:42 pm | N/A 2034-03-01 | Aligos Therapeutics Inc. | ALGS | Calhoun Lesley Ann See Remarks | 308,940 | $0 | 308,940 (Direct) | View |
| 2024-03-01 Option Award | 2024-03-04 5:42 pm | N/A 2034-03-01 | Aligos Therapeutics Inc. | ALGS | Symons Julian A. See Remarks | 72,000 | $0 | 72,000 (Direct) | View |
| 2024-03-01 Option Award | 2024-03-04 5:41 pm | N/A 2024-03-01 | Aligos Therapeutics Inc. | ALGS | BLATT LAWRENCE Chief Executive Officer | 965,435 | $0 | 965,435 (Direct) | View |
| 2024-02-27 Disposition | 2024-02-28 5:35 pm | 2022-06-17 2031-06-17 | Aligos Therapeutics Inc. | ALGS | Hirth Peter Director | 15,000 | $0 | 4,411 (Direct) | View |
| 2024-02-28 Option Award | 2024-02-28 5:35 pm | N/A 2031-06-17 | Aligos Therapeutics Inc. | ALGS | Hirth Peter Director | 4,411 | $0 | 4,411 (Direct) | View |
| 2024-02-27 Disposition | 2024-02-28 5:34 pm | 2021-05-26 2031-04-26 | Aligos Therapeutics Inc. | ALGS | Scopa James Paul Director | 30,000 | $0 | 8,823 (Direct) | View |
| 2024-02-28 Option Award | 2024-02-28 5:34 pm | N/A 2031-04-26 | Aligos Therapeutics Inc. | ALGS | Scopa James Paul Director | 8,823 | $0 | 8,823 (Direct) | View |
| 2024-02-27 Disposition | 2024-02-28 5:33 pm | 2021-01-01 2030-12-01 | Aligos Therapeutics Inc. | ALGS | McClure Matthew W. Chief Medical Officer | 370,626 | $0 | 157,324 (Direct) | View |
| 2024-02-28 Option Award | 2024-02-28 5:33 pm | N/A 2030-12-01 | Aligos Therapeutics Inc. | ALGS | McClure Matthew W. Chief Medical Officer | 157,324 | $0 | 157,324 (Direct) | View |
| 2024-02-27 Disposition | 2024-02-28 5:32 pm | 2021-01-01 2030-12-01 | Aligos Therapeutics Inc. | ALGS | Calhoun Lesley Ann See Remarks | 307,487 | $0 | 145,581 (Direct) | View |
| 2024-02-28 Option Award | 2024-02-28 5:32 pm | N/A 2030-12-01 | Aligos Therapeutics Inc. | ALGS | Calhoun Lesley Ann See Remarks | 145,581 | $0 | 145,581 (Direct) | View |
| 2024-02-27 Disposition | 2024-02-28 5:32 pm | 2021-01-01 2030-12-01 | Aligos Therapeutics Inc. | ALGS | BLATT LAWRENCE Chief Executive Officer | 854,250 | $0 | 421,100 (Direct) | View |
| 2024-02-28 Option Award | 2024-02-28 5:32 pm | N/A 2030-12-01 | Aligos Therapeutics Inc. | ALGS | BLATT LAWRENCE Chief Executive Officer | 421,100 | $0 | 421,100 (Direct) | View |
| 2024-02-27 Disposition | 2024-02-28 5:31 pm | 2021-01-01 2030-12-01 | Aligos Therapeutics Inc. | ALGS | Symons Julian A. See Remarks | 331,250 | $0 | 152,570 (Direct) | View |
| 2024-02-28 Option Award | 2024-02-28 5:31 pm | N/A 2030-12-01 | Aligos Therapeutics Inc. | ALGS | Symons Julian A. See Remarks | 152,570 | $0 | 152,570 (Direct) | View |
| 2024-02-27 Disposition | 2024-02-28 5:30 pm | 2022-06-17 2031-06-17 | Aligos Therapeutics Inc. | ALGS | Nielsen Jack Director | 15,000 | $0 | 4,411 (Direct) | View |
| 2024-02-28 Option Award | 2024-02-28 5:30 pm | N/A 2031-06-17 | Aligos Therapeutics Inc. | ALGS | Nielsen Jack Director | 4,411 | $0 | 4,411 (Direct) | View |
| 2024-02-27 Disposition | 2024-02-28 5:29 pm | 2022-06-17 2031-06-17 | Aligos Therapeutics Inc. | ALGS | Nuechterlein Carole Director | 15,000 | $0 | 4,411 (Direct) | View |
| 2024-02-28 Option Award | 2024-02-28 5:29 pm | N/A 2031-06-17 | Aligos Therapeutics Inc. | ALGS | Nuechterlein Carole Director | 4,411 | $0 | 4,411 (Direct) | View |
| 2024-02-27 Disposition | 2024-02-28 5:29 pm | 2021-12-16 2031-11-16 | Aligos Therapeutics Inc. | ALGS | Martell Bridget A Director | 30,000 | $0 | 8,823 (Direct) | View |
| 2024-02-28 Option Award | 2024-02-28 5:29 pm | N/A 2031-11-16 | Aligos Therapeutics Inc. | ALGS | Martell Bridget A Director | 8,823 | $0 | 8,823 (Direct) | View |
Ownership | 2023-11-07 5:14 pm | N/A N/A | Aligos Therapeutics Inc. | ALGS | ROCHE HOLDING LTD ROCHE FINANCE LTD 10% Owner | 0 | $0 | 14,992,741 (Indirect) | View |
| 2023-10-25 Option Award | 2023-10-27 4:14 pm | N/A N/A | Aligos Therapeutics Inc. | ALGS | BLATT LAWRENCE Chief Executive Officer | 610,277 | $0.7568 | 2,425,771 (Direct) | View |
| 2023-10-25 Option Award | 2023-10-27 4:14 pm | 2023-10-25 2030-10-25 | Aligos Therapeutics Inc. | ALGS | BLATT LAWRENCE Chief Executive Officer | 305,138 | $0.125 | 2,425,771 (Direct) | View |
| 2023-10-25 Option Award | 2023-10-27 4:13 pm | N/A N/A | Aligos Therapeutics Inc. | ALGS | Scopa James Paul Director | 183,083 | $0.7568 | 274,624 (Direct) | View |
| 2023-10-25 Option Award | 2023-10-27 4:13 pm | 2023-10-25 2030-10-25 | Aligos Therapeutics Inc. | ALGS | Scopa James Paul Director | 91,541 | $0.125 | 274,624 (Direct) | View |
| 2023-09-08 Option Award | 2023-09-12 4:08 pm | N/A 2033-09-08 | Aligos Therapeutics Inc. | ALGS | McClure Matthew W. Chief Medical Officer | 48,000 | $0 | 48,000 (Direct) | View |
| 2023-09-08 Option Award | 2023-09-12 4:07 pm | N/A 2033-09-08 | Aligos Therapeutics Inc. | ALGS | Calhoun Lesley Ann See Remarks | 48,000 | $0 | 48,000 (Direct) | View |
| 2023-09-08 Option Award | 2023-09-12 4:07 pm | N/A 2033-09-08 | Aligos Therapeutics Inc. | ALGS | Quan Lucinda Y. See Remarks | 48,000 | $0 | 48,000 (Direct) | View |
| 2023-09-08 Option Award | 2023-09-12 4:06 pm | N/A 2033-09-08 | Aligos Therapeutics Inc. | ALGS | Symons Julian A. See Remarks | 48,000 | $0 | 48,000 (Direct) | View |
| 2023-09-08 Option Award | 2023-09-12 4:05 pm | N/A 2033-09-08 | Aligos Therapeutics Inc. | ALGS | BLATT LAWRENCE Chief Executive Officer | 150,000 | $0 | 150,000 (Direct) | View |
| 2023-07-20 Option Award | 2023-07-21 9:06 pm | N/A 2033-07-20 | Aligos Therapeutics Inc. | ALGS | Martell Bridget A Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2023-07-20 Option Award | 2023-07-21 7:23 pm | N/A 2033-07-20 | Aligos Therapeutics Inc. | ALGS | Nielsen Jack Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2023-07-20 Option Award | 2023-07-21 4:13 pm | N/A 2033-07-20 | Aligos Therapeutics Inc. | ALGS | Hirth Peter Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2023-07-20 Option Award | 2023-07-21 4:11 pm | N/A 2033-07-20 | Aligos Therapeutics Inc. | ALGS | Scopa James Paul Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2023-07-20 Option Award | 2023-07-21 4:10 pm | N/A 2033-07-20 | Aligos Therapeutics Inc. | ALGS | Nuechterlein Carole Director | 20,000 | $0 | 20,000 (Direct) | View |